Our previous preclinical and clinical studies have demonstrated the favorable properties of the [18F]-JK-PSMA-7 ligand for tumor localization after biochemical recurrence and its robust synthesis [5, 7]. This evidence concerns the gene FOLH1 and neoplasm.